FIGURE

Fig. 3

ID

ZDB-FIG-180828-15

Publication

Tan et al., 2018 - Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish

Other Figures

All Figure Page

Back to All Figure Page

Fig. 3

Doxorubicin inhibition of MLL-AF9-induced hematopoiesis. Doxorubicin and DMSO (control) were administered to MLL-AF9-injected and wild-type embryos from 24 to 48hpf. WISH assays of the (a) definitive hematopoietic stem cell marker c-myb and (b–d) myeloid lineage markers mpo, lyz, and l-plastin in wild-type embryos treated with DMSO (top), MLL-AF9-injected embryos treated with DMSO (middle), and MLL-AF9-injected embryos treated with doxorubicin (bottom) at 48hpf. (e) Relative expression of the marker genes for definitive hematopoiesis (runx1 and c-myb) and myeloid hematopoiesis (l-plastin, csf1r, mfap4, mpo, and lyz) in wild-type and MLL-AF9-injected embryos treated with DMSO or doxorubicin analyzed by qRT-PCR. Wild-type embryos treated with DMSO were used as a control.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Biomed Res. Int.